Press Releases

 Sign up for email alerts here

 

Date Title and Summary Additional Formats
Toggle Summary Genocea Biosciences Closes $35 Million Series B Financing View HTML
Toggle Summary Genocea Biosciences Announces Promotion of Chip Clark to President and Chief Executive Officer View HTML
Toggle Summary Results from Genocea Pneumococcus Vaccine Collaboration with Children’s Hospital of Boston and PATH Published in Cell Host & Microbe View HTML
Toggle Summary Genocea funding highlights growing investor interest
Genocea Biosciences Inc., a Cambridge-based developer of T cell-based vaccines, took in a venture capital round worth $35 million in January. The size of the deal is one signal of increasing investor confidence in the vaccines industry at a time when pharmaceutical companies are seeing dwindling
View HTML
Toggle Summary Leveraging Natural Immunity to Find New Vaccines View HTML
Toggle Summary Genocea will be presenting some of its recent work at the biennial Chlamydia Basic Research Society Meeting in Redondo Beach, California View HTML
Toggle Summary Genocea will be presenting some of its work at the World Vaccine Congress 2011 in Washington, D.C. View HTML
Toggle Summary Genocea will be presenting some of its work at the 5th Semmering Vaccines Symposium 2011 View HTML
Toggle Summary Jessica Baker Flechtner, VP of Research, to present at the 2011 BIO International Convention, June 28, 2011, in Washington, D.C. View HTML
Toggle Summary Genocea Biosciences Hires Ravi Venkataramani, Ph.D. as Vice President, Business Development View HTML